Health Maintenance Guidelines
Definitions
Body Mass Index (BMI): Your weight in relateion to your height.
How to calculate your BMI: Weight (pounds) / Height (inches) x 703
- BMI Range for Non-Asian Ethnicities:
Underweight: Under 19
Healthy: 19 – 24.9
Overweight: 25 – 29.9
Obese: Greater than 29.9
– BMI Range for Asian Ethnicities:
Underweight: Under 18.5
Healthy: 18.5 – 23
Overweight: 23.1 – 25
Obese: Greater than 25
www.wpro.who.int/internet/resources.ashx/NUT/Redefining+obesity.pdf
Bone Density Test: A low dose x-ray to screen for risk of thinning and weakening of bones, which increase the risk of osteoporosis and fracture.
Chlamydia/GC Screening Test: A screening test for detecting chlamydia and/or gonorrhea. Curable sexually transmitted infections that can cause scarring, infertility and chronic pelvic pain.
Depression Screening: A formal questionnaire to detect major depression in adolescence and adults. Administer testing if treatment is available for the detection and treatment of major depression.
Fecal Occult Blood Test: A screening test for hidden blood in the stool, which may be a sign of colon cancer. High sensitivity fecal occult test is preferred.
HIV Test: A blood test to detect the presence of human immunodeficiency virus - a treatable infectious disease.
Lipid Screen: A blood test for assessing levels of fats and cholesterol that can increase the risk of heart disease and stroke.
Lower GI Endoscopy:
- Colonoscopy: An internal inspection of the entire colon to screen for cancer and polyps (pre-cancerous growths).
- Sigmoidoscopy: An internal inspection of the lower colon to screen for cancer and polyps (pre-cancerous growths)
Pap Test: A test for abnormal cervical cells which can indicate increased risk of cervical cancer. This is not a test for uterine or ovarian cancer. Pap smears are done during an internal pelvic examination.
PSA: (Prostate Specific Antigen) A blood test for measuring a protein produced by the prostate gland. High levels may indicate prostate cancer.
Tdap: Tdap is currently recommended as a single dose for individuals age 11 through 64 years. Tdap is also recommended over age 6 years if prior DTaP cannot be documented and the individual has close contact with infants.
